Compounds > methyl 4,6-o-(1-carboxyethylidene)galactopyranoside
Page last updated: 2024-09-03

methyl 4,6-o-(1-carboxyethylidene)galactopyranoside and edetic acid

methyl 4,6-o-(1-carboxyethylidene)galactopyranoside has been researched along with edetic acid in 1 studies

Compound Research Comparison

Studies
(methyl 4,6-o-(1-carboxyethylidene)galactopyranoside)		Trials
(methyl 4,6-o-(1-carboxyethylidene)galactopyranoside)		Recent Studies (post-2010)
(methyl 4,6-o-(1-carboxyethylidene)galactopyranoside)		Studies
(edetic acid)		Trials
(edetic acid)		Recent Studies (post-2010) (edetic acid)
50027,5536293,970

Protein Interaction Comparison

ProteinTaxonomymethyl 4,6-o-(1-carboxyethylidene)galactopyranoside (IC50)edetic acid (IC50)
Amyloid-beta precursor proteinHomo sapiens (human)7.7
Beta-lactamase VIM-1 Pseudomonas aeruginosa9.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, PM; Hind, CR; Pepys, MB1

Other Studies

1 other study(ies) available for methyl 4,6-o-(1-carboxyethylidene)galactopyranoside and edetic acid

ArticleYear
Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose.
    Biochimica et biophysica acta, 1984, Nov-06, Volume: 802, Issue:1

    Topics: Amyloid; Calcium; Chemical Precipitation; Edetic Acid; Humans; Methylgalactosides; Methylglycosides; Serum Amyloid P-Component

1984